| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 2 | 2 | — | — | 3 | — | 3 | — | — | — | 2 | 2 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 3.54 |
—
—
—
|
| 2025 | 3.15 |
—
—
—
—
—
|
| 2024 | 2.14 |
—
—
—
|
| 2023 | 2.66 |
—
—
—
—
|
| 2022 | 2.32 |
—
—
—
—
|
| 2021 | 1.80 |
—
—
—
—
|
| 2020 | 1.54 |
—
—
—
—
|
| 2019 | 1.46 |
—
—
—
—
|
| 2018 | 1.30 |
—
—
—
—
|
| 2017 | 1.14 |
—
—
—
—
|
| 2016 | 1.02 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 115.68 | 115.95 | 108.44 | 113.43 |
| Receivables | 590.89 | 594.66 | 587.84 | 648.83 |
| Inventory | 454.78 | 476.94 | 444.81 | 469.31 |
| Other | 67.97 | 87.48 | 101.75 | 96.30 |
| 1,229.31 | 1,275.03 | 1,242.85 | 1,327.87 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 106.32 | 97.84 | 121.01 | 154.63 |
| ST’ Debt | 115.66 | 103.93 | 315.00 | 202.00 |
| Other | — | — | — | — |
| 582.09 | 528.48 | 758.26 | 728.47 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 669.46 | 740.85 | 817.67 | — |
—
|
| ’25 | 615.42 | 682.94 | 741.51 | 751.82 |
2,791.69
|
| ’24 | 633.19 | 650.64 | 661.60 | 744.48 |
2,689.92
|
| ’23 | 610.48 | 650.17 | 648.68 | 719.31 |
2,628.63
|
| ’22 | 609.17 | 635.40 | 662.13 | 683.58 |
2,590.28
|
| ’21 | 526.57 | 589.54 | 646.86 | 599.25 |
2,362.21
|
| ’20 | 494.92 | 529.48 | 538.18 | 558.53 |
2,121.10
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 140.43 | 180.67 | 249.37 | — |
—
|
| ’25 | 159.12 | 119.17 | 237.97 | 202.91 |
719.18
|
| ’24 | 172.36 | 122.61 | 164.85 | 96.38 |
556.19
|
| ’23 | 123.34 | 164.57 | 190.17 | 163.21 |
641.28
|
| ’22 | 118.09 | 96.41 | 125.19 | 173.44 |
513.13
|
| ’21 | 143.29 | 104.43 | 127.74 | 170.47 |
545.93
|
| ’20 | 116.28 | 101.90 | 91.78 | 192.46 |
502.42
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 124.02 | 170.50 | 236.75 | — |
—
|
| ’25 | 138.02 | 103.13 | 226.42 | 193.86 |
661.42
|
| ’24 | 164.85 | 108.24 | 143.00 | 75.77 |
491.86
|
| ’23 | 114.04 | 158.55 | 181.32 | 152.88 |
606.80
|
| ’22 | 105.60 | 84.14 | 110.99 | 161.25 |
461.98
|
| ’21 | 135.39 | 93.65 | 118.43 | 160.32 |
507.79
|
| ’20 | 102.46 | 89.99 | 81.58 | 178.70 |
452.73
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 2.38 | 2.09 | 2.73 | — |
—
|
| ’25 | 1.65 | 1.97 | 2.22 | 2.69 |
8.51
|
| ’24 | 1.90 | 2.05 | 2.04 | 2.12 |
8.11
|
| ’23 | 1.81 | 2.21 | 2.22 | 2.22 |
8.46
|
| ’22 | 2.05 | 1.88 | 2.45 | 2.44 |
8.81
|
| ’21 | 1.32 | 2.12 | 2.42 | 1.88 |
7.74
|
| ’20 | 0.89 | 1.58 | 1.49 | 0.31 |
4.27
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 194.89 | 202.57 | 206.80 | 165.03 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 256.14 | 265.99 | 279.38 | 251.47 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,331 | 7,900 | 8,000 | 8,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.33 | 0.34 | 0.35 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,590.28 | 2,628.63 | 2,689.92 | 2,791.69 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.07% | 54.23% | 55.25% | 55.16% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 649.28 | 615.34 | 585.48 | 597.65 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.07% | 23.41% | 21.77% | 21.41% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 513.10 | 487.49 | 467.28 | 484.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 99.92 | 111.90 | 136.18 | 150.52 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.95 | 46.04 | 47.05 | 49.32 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 8.90 | 8.54 | 8.17 | 8.56 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.90 | 11.23 | 9.73 | 12.70 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.89) | (0.60) | (1.13) | (1.02) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.02 | 10.63 | 8.60 | 11.68 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.81 | 45.51 | 51.28 | 53.77 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 57.63 | 57.09 | 57.18 | 56.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.25 | 24.92 | 30.30 | 27.07 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.01 | 4.62 | 5.27 | 4.70 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.65 | 4.67 | 4.83 | 4.31 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.23 | 5.24 | 6.05 | 5.38 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.33 | 22.69 | 33.09 | 22.72 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 513.13 | 641.28 | 556.19 | 719.18 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (51.15) | (34.48) | (64.33) | (57.75) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 461.98 | 606.80 | 491.86 | 661.42 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 298.77 | 647.22 | 746.56 | 484.59 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 749.04 | 1,748.73 | 2,217.21 | 2,004.61 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 585.58 | 1,633.05 | 2,101.26 | 1,896.17 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,294.38 | 2,598.06 | 2,932.19 | 3,043.57 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.48% | 10.75% | 8.31% | 8.13% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.24% | 9.94% | 8.37% | 9.01% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.04% | 19.93% | 16.90% | 16.21% | — | — | — |
ROE
|
Nordson Corporation (NDSN) exemplifies resilient growth in precision adhesive dispensing, riding megatrends like EV battery assembly, semiconductors, and medical devices amid surging automation demand. Revenue has surged 45% from $1.81 billion in 2016 to $2.63 billion in 2023, with analysts forecasting acceleration to $3.24 billion by 2028—implying mid-teens CAGR fueled by strategic acquisitions like CyberOptics and operational leverage, where revenue per employee consistently tops $300,000, signaling scalable innovation without headcount bloat.
Profitability remains robust, with gross margins steady at 53-56%, EPS climbing from $4.76 to a projected $12.08 by 2028 (over 150% cumulative growth), and free cash flow per share more than doubling to near $12. Nordson’s fortress balance sheet—equity up 204% to $2.59 billion—supports disciplined capital allocation via buybacks, modest capex, and M&A, while ROIC and ROE outperform peers. Trading at compelling 22.7x EV/FCF amid undervalued PS ratios, the stock has outpaced fundamentals, with catalysts like CHIPS Act tailwinds and recurring consumables revenue (60%+) poised to drive 20-30% upside—if cyclical risks don’t derail the disruptive edge.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.